Pharmacology letter accelerated communicationA new extrapolation method from animals to man: Application to a metabolized compound, mofarotene
References (10)
- et al.
J. Biol. Chem.
(1964) - et al.
Anal. Biochem.
(1985) - et al.
Biochem. Pharmacol.
(1988) J. Pharm. Sci.
(1986)
There are more references available in the full text version of this article.
Cited by (32)
Allometric principles for interspecies extrapolation in toxicological risk assessment - Empirical investigations
2004, Regulatory Toxicology and PharmacologyPhysiologically based pharmacokinetic (PBPK) modeling of disposition of epiroprim in humans
2003, Journal of Pharmaceutical SciencesCitation Excerpt :Some of these approaches employ time normalizations8,9 or other scaling factors that include: protein binding, brain weight,10 or maximum life span potential.11 The use of bile flow rates, and/or in vitro microsome or hepatocyte data, or UDP–glucuronosyltransferase activity to normalize the in vivo CL have also substantially improved the prediction of the in vivo human clearance for drugs that are eliminated via liver metabolism,12–14 either alone or combined with biliary excretion.15,16 In contrast to allometric scaling, the physiologically based pharmacokinetic (PBPK) models provide an opportunity to integrate the data from a variety of processes, to predict the pharmacokinetic profiles.2
Anaesthesia in the fourth dimension. Is biological scaling relevant to veterinary anaesthesia?
2000, Veterinary Anaesthesia and AnalgesiaIntegration of in vitro data and brain weight in allometric scaling to predict clearance in humans: Some suggestions
1998, Journal of Pharmaceutical SciencesIntegration of in vitro data into allometric scaling to predict hepatic metabolic clearance in man: Application to 10 extensively metabolized drugs
1997, Journal of Pharmaceutical SciencesPrediction of metabolism of drugs using artificial intelligence: How far have we reached?
2016, Current Drug Metabolism
Copyright © 1995 Published by Elsevier Inc.